Jack Hirschowitz

1.9k total citations
63 papers, 1.4k citations indexed

About

Jack Hirschowitz is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Jack Hirschowitz has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 9 papers in Biological Psychiatry and 8 papers in Pharmacology. Recurrent topics in Jack Hirschowitz's work include Schizophrenia research and treatment (34 papers), Bipolar Disorder and Treatment (24 papers) and Tryptophan and brain disorders (9 papers). Jack Hirschowitz is often cited by papers focused on Schizophrenia research and treatment (34 papers), Bipolar Disorder and Treatment (24 papers) and Tryptophan and brain disorders (9 papers). Jack Hirschowitz collaborates with scholars based in United States. Jack Hirschowitz's co-authors include David L. Garver, Robert Hitzemann, Frank P. Zemlan, Donald R. Kanter, David L. Garver, D. Garver, Frederic J. Sautter, Seth Apter, Sidney S. Chang and Amir Garakani and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Jack Hirschowitz

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Hirschowitz United States 22 812 272 209 164 144 63 1.4k
Ronald Brenner United States 25 933 1.1× 282 1.0× 157 0.8× 311 1.9× 175 1.2× 60 1.6k
Joseph F. Lipinski United States 25 874 1.1× 337 1.2× 241 1.2× 235 1.4× 360 2.5× 43 1.7k
Nigel Bark United States 13 666 0.8× 206 0.8× 153 0.7× 79 0.5× 275 1.9× 30 1.2k
T. Kolakowska United Kingdom 18 905 1.1× 172 0.6× 166 0.8× 115 0.7× 191 1.3× 30 1.2k
Michael D. Jibson United States 17 944 1.2× 160 0.6× 118 0.6× 169 1.0× 280 1.9× 57 1.5k
Wolfgang Fleischhacker Austria 14 922 1.1× 182 0.7× 227 1.1× 154 0.9× 238 1.7× 28 1.5k
J. Ananth Canada 20 736 0.9× 471 1.7× 244 1.2× 262 1.6× 328 2.3× 92 1.8k
W. Rein France 16 1.1k 1.3× 305 1.1× 122 0.6× 469 2.9× 199 1.4× 48 1.5k
A. Klimke Germany 22 709 0.9× 286 1.1× 416 2.0× 247 1.5× 227 1.6× 79 1.7k
Henrik Lublin Denmark 25 1.3k 1.6× 392 1.4× 438 2.1× 251 1.5× 246 1.7× 59 2.0k

Countries citing papers authored by Jack Hirschowitz

Since Specialization
Citations

This map shows the geographic impact of Jack Hirschowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Hirschowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Hirschowitz more than expected).

Fields of papers citing papers by Jack Hirschowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Hirschowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Hirschowitz. The network helps show where Jack Hirschowitz may publish in the future.

Co-authorship network of co-authors of Jack Hirschowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Hirschowitz. A scholar is included among the top collaborators of Jack Hirschowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Hirschowitz. Jack Hirschowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirschowitz, Jack, A lexander Kolevzon, & Amir Garakani. (2010). The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances. Harvard Review of Psychiatry. 18(5). 266–278. 21 indexed citations
2.
Garakani, Amir, Jose M. Martinez, Sue M. Marcus, et al.. (2008). A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. International Clinical Psychopharmacology. 23(5). 269–275. 27 indexed citations
3.
Dunlop, Boadie W., Paul Crits‐Christoph, Dwight L. Evans, et al.. (2007). Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness. Journal of Clinical Psychopharmacology. 27(6). 614–619. 41 indexed citations
4.
Hirschowitz, Jack. (2005). Assessing and Managing Suicide Risk. The Journal of Clinical Psychiatry. 66(6). 804–805. 3 indexed citations
5.
Garakani, Amir, Jack Hirschowitz, & Craig L. Katz. (2004). General disaster psychiatry. Psychiatric Clinics of North America. 27(3). 391–406. 11 indexed citations
6.
McQuistion, Hunter L., Molly Finnerty, Jack Hirschowitz, & Ezra Susser. (2003). Challenges for Psychiatry in Serving Homeless People With Psychiatric Disorders. Psychiatric Services. 54(5). 669–676. 37 indexed citations
7.
Hirschowitz, Jack, et al.. (1997). The Dose Reduction in Schizophrenia (DORIS) study: a final report. Schizophrenia Research. 23(1). 31–43. 9 indexed citations
8.
Harvey, Philip D., Michael Davidson, Leonard White, et al.. (1996). Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: Effects of typical neuroleptics on the brief psychiatric rating scale. Biological Psychiatry. 40(8). 755–760. 33 indexed citations
9.
Stern, Robert G., et al.. (1993). Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Research. 46(2). 151–163. 39 indexed citations
10.
Stern, Robert G., RenéS. Kahn, Philip D. Harvey, et al.. (1993). Early response to haloperidol treatment in chronic schizophrenia. Schizophrenia Research. 10(2). 165–171. 31 indexed citations
11.
Kahn, René S., et al.. (1992). Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects. Psychiatry Research. 41(2). 155–161. 15 indexed citations
12.
Hirschowitz, Jack, et al.. (1992). A Comparison of Hospital Charting Practices for Patients With Schizophrenia. Psychiatric Services. 43(4). 392–393. 2 indexed citations
13.
Volkow, Nora D., Robert Hitzemann, Alfred P. Wolf, et al.. (1990). Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Research Neuroimaging. 35(1). 39–48. 148 indexed citations
14.
Choc, Miles G., Francis Hsuan, Gilbert Honigfeld, et al.. (1990). Single- vs Multiple-Dose Pharmacokinetics of Clozapine in Psychiatric Patients. Pharmaceutical Research. 7(4). 347–351. 60 indexed citations
15.
Hirschowitz, Jack, et al.. (1989). Lithium antagonism of ethanol-induced intoxication: Relationship to intracellular lithium levels. Psychiatry Research. 29(1). 55–63. 1 indexed citations
16.
Hitzemann, Robert, et al.. (1989). RBC lithium transport in the psychoses. Biological Psychiatry. 25(3). 296–304. 12 indexed citations
17.
Garver, David L., et al.. (1988). Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias). Psychological Medicine. 18(4). 873–885. 43 indexed citations
18.
Brown, Daniel F., et al.. (1985). The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.. PubMed. 46(6). 222–5. 76 indexed citations
19.
Garver, David L., et al.. (1984). Dopamine and non-dopamine psychoses. Psychopharmacology. 84(1). 138–140. 18 indexed citations
20.
Breier, Alan, Robert Hitzemann, Jack Hirschowitz, & David L. Garver. (1981). Kinetic analysis of platelet monoamine oxidase in chronic schizophrenia. Life Sciences. 28(17). 1947–1951. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Brenner Breakdown of academic impact, for papers by Joseph F. Lipinski Breakdown of academic impact, for papers by Nigel Bark Breakdown of academic impact, for papers by T. Kolakowska Breakdown of academic impact, for papers by Michael D. Jibson Breakdown of academic impact, for papers by Wolfgang Fleischhacker Breakdown of academic impact, for papers by J. Ananth Breakdown of academic impact, for papers by W. Rein Breakdown of academic impact, for papers by A. Klimke Breakdown of academic impact, for papers by Henrik Lublin
Rankless by CCL
2026